Home » Topics » BioWorld Science

BioWorld Science
RSS

Inceptor Bio uses seed funding to advance next-generation cell therapy platforms for cancer

June 14, 2021

New target identified for acetaminophen liver injury

June 14, 2021

Rohto initiates phase I/II study of UDI-001 in pediatric patients with cerebral palsy

June 14, 2021

Dosing begins in phase I study of novel cystic fibrosis therapy ETD-001

June 14, 2021

ImmVira completes first dosing in phase II trials of oncolytic virus product MVR-T3011

June 14, 2021

Preliminary assessment of [68Ga]NOTA-GUL for the diagnosis of prostate cancer

June 14, 2021

Novavax reports COVID-19 vaccine data against SARS-CoV-2 Beta variant

June 14, 2021

Preliminary phase I results for NEXI-002 in R/R MM reported at EHA

June 14, 2021

Phase Ia/b data for APTO-253 in patients with relapsed/refractory AML or high-risk MDS

June 14, 2021

U.K.'s MHRA clears initiation of phase II trial of COVID-DROPS

June 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...